FDA Inspection 1194883 — Carter Bloodcare - Allen
The FDA completed an inspection of Carter Bloodcare - Allen on Jan 18, 2023 in Allen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Allen, TX (United States)